Holm K., Mäki M., Vuolteenaho N., Mustalahti K., Ashorn M., Ruuska T., Kaukinen K. Oats in the treatment of childhood coeliac disease: a 2-year controlled trial and a long-term clinical follow-up study. „Alimentary pharmacology & therapeutics”. 10 (23), s. 1463–1472, maj 2006. DOI: 10.1111/j.1365-2036.2006.02908.x. PMID: 16669961.
Alessio Fasano, Irene Berti, Tania Gerarduzzi, Tarcisio Not i inni. Prevalence of Celiac Disease in At-Risk and Not-At-Risk Groups in the United States. „Archives of Internal Medicine”. 163 (3), s. 286, 2003-02-10. American Medical Association (AMA). DOI: 10.1001/archinte.163.3.286. ISSN0003-9926. (ang.).
S. Lohi, K. Mustalahti, K. Kaukinen, K. Laurila, P. Collin, H. Rissanen, O. Lohi, E. Bravi, M. Gasparin, A. Reunanen, M. Mäki. Increasing prevalence of coeliac disease over time. „Alimentary Pharmacology & Therapeutics”, 2007-10. DOI: 10.1111/j.1365-2036.2007.03502.x.
Jessica R. Jackson, William W. Eaton, Nicola G. Cascella, Alessio Fasano, and Deanna L. Kelly. Neurologic and Psychiatric Manifestations of Celiac Disease and Gluten Sensitivity. „Psychiatr Q.”, 2012-03. DOI: 10.1007/s11126-011-9186-y. PMID: 21877216. PMCID: PMC3641836.
Lammers K.M., Lu R., Brownley J., Lu B., Gerard C., Thomas K., Rallabhandi P., Shea-Donohue T., Tamiz A., Alkan S., Netzel-Arnett S., Antalis T., Vogel S.N., Fasano A. Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3. „Gastroenterology”, 2008-07. DOI: 10.1053/j.gastro.2008.03.023. PMID: 18485912.
Fleckenstein B., Molberg Ø., Qiao S.W., Schmid D.G., von der Mülbe F., Elgstøen K., Jung G., Sollid L.M. Gliadin T cell epitope selection by tissue transglutaminase in celiac disease. Role of enzyme specificity and pH influence on the transamidation versus deamidation process. „J Biol Chem.”, 2002-11. DOI: 10.1074/jbc.M204521200. PMID: 12093810.
Chu-Young Kim, Hanne Quarsten, Elin Bergseng, Chaitan Khosla, Ludvig M. Sollid. Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease. „Proc Natl Acad Sci U S A”, 2004-03-24. DOI: 10.1073/pnas.0306885101. PMID: 15020763. PMCID: PMC384714.
Akobeng A.K., Thomas A.G. Systematic review: tolerable amount of gluten for people with coeliac disease. „Aliment Pharmacol Ther.”, 2008. DOI: 10.1111/j.1365-2036.2008.03669.x.. PMID: 18315587.
Ludvigsson J.F., Leffler D.A., Bai J.C., Biagi F., Fasano A., Green P.H., Hadjivassiliou M., Kaukinen K., Kelly C.P., Leonard J.N., Lundin K.E., Murray J.A., Sanders D.S., Walker M.M., Zingone F., Ciacci C. The Oslo definitions for coeliac disease and related terms. „Gut”, 2013-01. DOI: 10.1136/gutjnl-2011-301346. PMID: 22345659. PMCID: PMC3440559.
A. Rubio-Tapia, J.A. Murray. Classification and management of refractory coeliac disease.. „Gut”. 59 (4), s. 547–557, Apr 2010. DOI: 10.1136/gut.2009.195131. PMID: 20332526.
W.H. Verbeek, M.S. Goerres, B.M. von Blomberg, J.J. Oudejans i inni. Flow cytometric determination of aberrant intra-epithelial lymphocytes predicts T-cell lymphoma development more accurately than T-cell clonality analysis in Refractory Celiac Disease.. „Clin Immunol”. 126 (1), s. 48–56, Jan 2008. DOI: 10.1016/j.clim.2007.09.002. PMID: 18024205.
David H. Dewar, Suzanne C. Donnelly, Simon D. McLaughlin, Matthew W. Johnson, H. Julia Ellis, and Paul J. Ciclitira. Celiac disease: Management of persistent symptoms in patients on a gluten-free diet. „World J Gastroenterol.”, 2012-03. DOI: 10.3748/wjg.v18.i12.1348. PMCID: PMC3319961.
A. Al-toma, W.H.M. Verbeek, M. Hadithi, B.M.E. von Blomberg, C.J.J. Mulder. Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience. „Gut.”, 2007-10. DOI: 10.1136/gut.2006.114512. PMID: 17470479. PMCID: PMC2000250.
S.A. Scanlon, J.A. Murray. Update on celiac disease – etiology, differential diagnosis, drug targets, and management advances.. „Clin Exp Gastroenterol”. 4, s. 297–311, 2011. DOI: 10.2147/CEG.S8315. PMID: 22235174. PMCID: PMC3254208.
C.P. Kelly, P.H.R. Green, J.A. Murray, A. DiMarino, A. Colatrella, D.A. Leffler, T. Alexander, R. Arsenescu, F. Leon, J.G. Jiang, L.A. Arterburner, B.M. Paterson, R.N. Fedorak. Larazotide Acetate in Patients With Coeliac Disease Undergoing a Gluten Challenge. „Aliment Pharmacol Ther.”, 2013. [dostęp 2014-04-14].brak numeru strony
Anna Chmielewska, Piotr Dziechciarz, Dorota Gieruszczak-Białek, Andrea Horvath, Zofia Konarska, Bernadeta Patro, Małgorzata Pieścik-Lech, Marek Ruszczyński, Hanna Szajewska. Postępy w żywieniu i wybranych chorobach przewodu pokarmowego u dzieci w 2012 roku. „Medycyna Praktyczna. Pediatria”, 2013-03. Medycyna Praktyczna. [dostęp 2014-04-05].brak numeru strony
Kupper C. Dietary guidelines and implementation for celiac disease. „Gastroenterology”, 2005-04. PMID: 15825119.
Srinivasan U., Leonard N., Jones E., Kasarda D.D., Weir D.G., O’Farrelly C., Feighery C. Absence of oats toxicity in adult coeliac disease. „BMJ (Clinical research ed.)”. 7068 (313), s. 1300–1301, listopad 1996. PMID: 8942690.
Holm K., Mäki M., Vuolteenaho N., Mustalahti K., Ashorn M., Ruuska T., Kaukinen K. Oats in the treatment of childhood coeliac disease: a 2-year controlled trial and a long-term clinical follow-up study. „Alimentary pharmacology & therapeutics”. 10 (23), s. 1463–1472, maj 2006. DOI: 10.1111/j.1365-2036.2006.02908.x. PMID: 16669961.
Detlef Schuppan, Melinda D. Dennis, Ciaran P. Kelly. Celiac Disease: Epidemiology, Pathogenesis, Diagnosis, and Nutritional Management. „Nutr Clin Care.”, 2005-04. PMID: 16013224.
T Not, K Horvath, ID Hill, J Partanen i inni. Celiac disease risk in the USA: high prevalence of antiendomysium antibodies in healthy blood donors.. „Scandinavian Journal of Gastroenterology”. 33 (5), s. 494–8, 1998. ISSN0036-5521. PMID: 9648988. (ang.).
Troncone R., Greco L., Mayer M., Mazzarella G., Maiuri L., Congia M., Frau F., De Virgiliis S., Auricchio S. In siblings of celiac children, rectal gluten challenge reveals gluten sensitization not restricted to celiac HLA. „Gastroenterology”, 1996-08. PMID: 8690196.
Mager D.R., Qiao J., Turner J. Vitamin D and K status influences bone mineral density and bone accrual in children and adolescents with celiac disease. „Eur J Clin Nutr.”, kwiecień 2012. PMID: 21970944.
Selva-O’Callaghan A., Casellas F., de Torres I., Palou E., Grau-Junyent J.M., Vilardell-Tarrés M. Celiac disease and antibodies associated with celiac disease in patients with inflammatory myopathy. „Muscle Nerve.”, 2007-01. PMID: 16967485.
Jessica R. Jackson, William W. Eaton, Nicola G. Cascella, Alessio Fasano, and Deanna L. Kelly. Neurologic and Psychiatric Manifestations of Celiac Disease and Gluten Sensitivity. „Psychiatr Q.”, 2012-03. DOI: 10.1007/s11126-011-9186-y. PMID: 21877216. PMCID: PMC3641836.
Lachance L.R., McKenzie K. Biomarkers of gluten sensitivity in patients with non-affective psychosis: a meta-analysis.. „Schizophr Res.”, 2014-01. PMID: 24368154.
Gluten Sensitivity Presenting as a Neuropsychiatric Disorder. „Gastroenterol Res Pract.”, 2014. PMID: 24693281.
Tersigni C., Castellani R., de Waure C., Fattorossi A., De Spirito M., Gasbarrini A., Scambia G., Di Simone N. Celiac disease and reproductive disorders: meta-analysis of epidemiologic associations and potential pathogenic mechanisms. „Hum Reprod Update.”, 2014-03-11. PMID: 24619876.
Volta U., Vincentini O., Quintarelli F., Felli C., Silano M. Low risk of colon cancer in patients with celiac disease. „Scand J Gastroenterol.”, 2014-03-13. PMID: 24621303.
Lammers K.M., Lu R., Brownley J., Lu B., Gerard C., Thomas K., Rallabhandi P., Shea-Donohue T., Tamiz A., Alkan S., Netzel-Arnett S., Antalis T., Vogel S.N., Fasano A. Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3. „Gastroenterology”, 2008-07. DOI: 10.1053/j.gastro.2008.03.023. PMID: 18485912.
Skovbjerg H., Norén O., Anthonsen D., Moller J., Sjöström H. Gliadin is a good substrate of several transglutaminases: possible implication in the pathogenesis of coeliac disease. „Scand J Gastroenterol.”, 2002. PMID: 12190095.
van Heel D.A., West J. Recent advances in coeliac disease. „Gut.”, 2006-07. PMID: 16766754.
Fleckenstein B., Molberg Ø., Qiao S.W., Schmid D.G., von der Mülbe F., Elgstøen K., Jung G., Sollid L.M. Gliadin T cell epitope selection by tissue transglutaminase in celiac disease. Role of enzyme specificity and pH influence on the transamidation versus deamidation process. „J Biol Chem.”, 2002-11. DOI: 10.1074/jbc.M204521200. PMID: 12093810.
Mowat A.M. Coeliac disease-a meeting point for genetics, immunology, and protein chemistry. „Lancet”, 2003-04. PMID: 12699968.
Koskinen L.L., Einarsdottir E., Korponay-Szabo I.R., Kurppa K., Kaukinen K., Sistonen P., Pocsai Z., Széles G., Adány R., Mäki M., Kere J., Saavalainen P. Fine mapping of the CELIAC2 locus on chromosome 5q31-q33 in the Finnish and Hungarian populations. „Tissue Antigens”, 2009-11. PMID: 19845895.
Chu-Young Kim, Hanne Quarsten, Elin Bergseng, Chaitan Khosla, Ludvig M. Sollid. Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease. „Proc Natl Acad Sci U S A”, 2004-03-24. DOI: 10.1073/pnas.0306885101. PMID: 15020763. PMCID: PMC384714.
Jores R.D., Frau F., Cucca F., Grazia Clemente M., Orrù S., Rais M., De Virgiliis S., Congia M. HLA-DQB1*0201 homozygosis predisposes to severe intestinal damage in celiac disease. „Lancet”, 2003-04. PMID: 12699968.
Anderson R.P., Henry M.J., Taylor R., Duncan E.L., Danoy P., Costa M.J., Addison K., Tye-Din J.A., Kotowicz M.A., Knight R.E., Pollock W., Nicholson G.C., Toh B.H., Brown M.A., Pasco J.A. A novel serogenetic approach determines the community prevalence of celiac disease and informs improved diagnostic pathways. „BMC Med.”, 2013-08. PMID: 23981538. PMCID: PMC3765645.
Polvi A., Arranz E., Fernandez-Arquero M., Collin P., Mäki M., Sanz A., Calvo C., Maluenda C., Westman P., de la Concha E.G., Partanen J. HLA-DQ2-negative celiac disease in Finland and Spain. „Hum Immunol.”, 1998-03. PMID: 9548076.
Chorzelski T.P., Sulej J., Tchorzewska H., Jablonska S., Beutner E.H., Kumar V. IgA class endomysium antibodies in dermatitis herpetiformis and coeliac disease.. „Ann N Y Acad Sci.”, 1983. PMID: 6586098.
Ströhle A., Wolters M., Hahn A. Celiac disease--the chameleon among the food intolerances. „Med Monatsschr Pharm.”, 2013-10. PMID: 24266248.
Akobeng A.K., Thomas A.G. Systematic review: tolerable amount of gluten for people with coeliac disease. „Aliment Pharmacol Ther.”, 2008. DOI: 10.1111/j.1365-2036.2008.03669.x.. PMID: 18315587.
Janeczko C.E., Sweeney K., Connaghan G. Supplemental vitamin K improves the stability of anticoagulation in a patient with low tissue stores of vitamin K secondary to coeliac disease. „BMJ Case Rep.”. PMID: 21686472.
Ludvigsson J.F., Leffler D.A., Bai J.C., Biagi F., Fasano A., Green P.H., Hadjivassiliou M., Kaukinen K., Kelly C.P., Leonard J.N., Lundin K.E., Murray J.A., Sanders D.S., Walker M.M., Zingone F., Ciacci C. The Oslo definitions for coeliac disease and related terms. „Gut”, 2013-01. DOI: 10.1136/gutjnl-2011-301346. PMID: 22345659. PMCID: PMC3440559.
A. Rubio-Tapia, J.A. Murray. Classification and management of refractory coeliac disease.. „Gut”. 59 (4), s. 547–557, Apr 2010. DOI: 10.1136/gut.2009.195131. PMID: 20332526.
Malamut G, Afchain P., Verkarre V., Lecomte T., Amiot A., Damotte D., Bouhnik Y., Colombel J.F., Delchier J.C., Allez M., Cosnes J., Lavergne-Slove A., Meresse B., Trinquart L., Macintyre E., Radford-Weiss I., Hermine O., Brousse N., Cerf-Bensussan N., Cellier C. Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II.. „Gastroenterology”, 2009-01. PMID: 19014942.
W.H. Verbeek, M.S. Goerres, B.M. von Blomberg, J.J. Oudejans i inni. Flow cytometric determination of aberrant intra-epithelial lymphocytes predicts T-cell lymphoma development more accurately than T-cell clonality analysis in Refractory Celiac Disease.. „Clin Immunol”. 126 (1), s. 48–56, Jan 2008. DOI: 10.1016/j.clim.2007.09.002. PMID: 18024205.
Woodward J. The management of refractory coeliac disease. „Ther Adv Chronic Dis.”, 2013-03. PMID: 23556127. PMCID: PMC3610261.
David H. Dewar, Suzanne C. Donnelly, Simon D. McLaughlin, Matthew W. Johnson, H. Julia Ellis, and Paul J. Ciclitira. Celiac disease: Management of persistent symptoms in patients on a gluten-free diet. „World J Gastroenterol.”, 2012-03. DOI: 10.3748/wjg.v18.i12.1348. PMCID: PMC3319961.
C. Cellier, N. Patey, L. Mauvieux, B. Jabri i inni. Abnormal intestinal intraepithelial lymphocytes in refractory sprue.. „Gastroenterology”. 114 (3), s. 471–481, Mar 1998. PMID: 9496937.
G.C. Alfsen, K. Beiske, H. Bell, P.F. Marton. Low-grade intestinal lymphoma of intraepithelial T lymphocytes with concomitant enteropathy-associated T cell lymphoma: case report suggesting a possible histogenetic relationship.. „Hum Pathol”. 20 (9), s. 909–913, Sep 1989. PMID: 2789173.
C. Cellier, E. Delabesse, C. Helmer, N. Patey i inni. Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac Disease Study Group.. „Lancet”. 356 (9225), s. 203–208, Jul 2000. PMID: 10963198.
N. Patey-Mariaud De Serre, C. Cellier, B. Jabri, E. Delabesse i inni. Distinction between coeliac disease and refractory sprue: a simple immunohistochemical method.. „Histopathology”. 37 (1), s. 70–77, Jul 2000. PMID: 10931221.
Enns R., Lay T., Bridges R. Use of azathioprine for nongranulomatous ulcerative jejunoileitis. „Can J Gastroenterol.”, 2009-09. PMID: 9347165.
A. Al-toma, W.H.M. Verbeek, M. Hadithi, B.M.E. von Blomberg, C.J.J. Mulder. Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience. „Gut.”, 2007-10. DOI: 10.1136/gut.2006.114512. PMID: 17470479. PMCID: PMC2000250.
Brar P., Lee S., Lewis S., Egbuna I., Bhagat G., Green P.H. Budesonide in the treatment of refractory celiac disease. „Am J Gastroenterol.”, 2007-10. PMID: 17581265.
Daum S., Ipczynski R., Heine B., Schulzke J.D., Zeitz M., Ullrich R. Therapy with budesonide in patients with refractory sprue. „Digestion.”, 2006. PMID: 16612091.
Vaidya A., Bolanos J., Berkelhammer C. Azathioprine in refractory sprue.. „Am J Gastroenterol.”, 1999-06. PMID: 10406270.
Wahab P.J., Crusius J.B., Meijer J.W., Uil J.J., Mulder C.J. Cyclosporin in the treatment of adults with refractory coeliac disease--an open pilot study. „Aliment Pharmacol Ther.”, 2000-01. PMID: 10848661.
Tack G.J., Verbeek W.H., Al-Toma A., Kuik D.J., Schreurs M.W., Visser O., Mulder C.J. Evaluation of Cladribine treatment in refractory celiac disease type II. „World J Gastroenterol.”, 2011=01. PMID: 21274381.
Al-Toma A., Goerres M.S., Meijer J.W., von Blomberg B.M., Wahab P.J., Kerckhaert J.A., Mulder C.J. Cladribine therapy in refractory celiac disease with aberrant T cells. „Clin Gastroenterol Hepatol.”, 2006-11. PMID: 16979946.
Vivas S., Ruiz de Morales J.M., Ramos F., Suárez-Vilela D. Alemtuzumab for refractory celiac disease in a patient at risk for enteropathy-associated T-cell lymphoma. „N Engl J Med.”, 2006-06. PMID: 16760460.
Turner S.M., Moorghen M, Probert C,S. Refractory coeliac disease: remission with infliximab and immunomodulators. „Eur J Gastroenterol Hepatol.”, 2005-06. PMID: 15879730.
Chaudhary R., Ghosh S. Infliximab in refractory coeliac disease. „Eur J Gastroenterol Hepatol.”, 2005-06. PMID: 15879720.
Schmidt C., Kasim E., Schlake W., Gerken G., Giese T., Stallmach A. TNF-alpha antibody treatment in refractory collagenous sprue: report of a case and review of the literature. „Z Gastroenterol. 2009-01”, 2009. PMID: 19533547.
Costantino G., della Torre A., Lo Presti M.A., Caruso R., Mazzon E., Fries W. Treatment of life-threatening type I refractory coeliac disease with long-term infliximab. „Dig Liver Dis.”, 2008-01. PMID: 17382609.
Mulder C.J., Wahab P.J., Meijer J.W., Metselaar E. A pilot study of recombinant human interleukin-10 in adults with refractory coeliac disease. „Eur J Gastroenterol Hepatol.”, 2001-10. PMID: 11711774.
Pinier M., Fuhrmann G., Verdu E.F., Leroux J.C. Prevention measures and exploratory pharmacological treatments of celiac disease. „Am J Gastroenterol.”, 2010-12. PMID: 20877349.
G.G. Pyle, B. Paaso, B.E. Anderson, D.D. Allen i inni. Effect of pretreatment of food gluten with prolyl endopeptidase on gluten-induced malabsorption in celiac sprue.. „Clin Gastroenterol Hepatol”. 3 (7), s. 687–694, Jul 2005. PMID: 16206502.
S.A. Scanlon, J.A. Murray. Update on celiac disease – etiology, differential diagnosis, drug targets, and management advances.. „Clin Exp Gastroenterol”. 4, s. 297–311, 2011. DOI: 10.2147/CEG.S8315. PMID: 22235174. PMCID: PMC3254208.
Matysiak-Budnik T., Candalh C., Cellier C., Dugave C., Namane A., Vidal-Martinez T., Cerf-Bensussan N., Heyman M. Limited efficiency of prolyl-endopeptidase in the detoxification of gliadin peptides in celiac disease. „Gastroenterology.”, 2009-09. PMID: 16143118.
Tye-Din J.A., Anderson R.P., Ffrench R.A., Brown G.J., Hodsman P., Siegel M., Botwick W., Shreeniwas R. The effects of ALV003 pre-digestion of gluten on immune response and symptoms in celiac disease in vivo. „Clin Immunol.”, 2010-03. PMID: 19942485.
Greco L., Gobbetti M., Auricchio R., Di Mase R., Landolfo F., Paparo F., Di Cagno R., De Angelis M., Rizzello C.G., Cassone A., Terrone G., Timpone L., D’Aniello M., Maglio M., Troncone R., Auricchio S. Safety for patients with celiac disease of baked goods made of wheat flour hydrolyzed during food processing. „Clin Gastroenterol Hepatol.”, 2011-01. PMID: 20951830.
Di Cagno R., De Angelis M., Auricchio S., Greco L., Clarke C., De Vincenzi M., Giovannini C., D’Archivio M., Landolfo F., Parrilli G., Minervini F., Arendt E., Gobbetti M. Sourdough bread made from wheat and nontoxic flours and started with selected lactobacilli is tolerated in celiac sprue patients. „Appl Environ Microbiol.”, 2014-02. PMID: 14766592.
De Angelis M., Rizzello C.G., Fasano A., Clemente M.G., De Simone C., Silano M., De Vincenzi M., Losito I., Gobbetti M. VSL#3 probiotic preparation has the capacity to hydrolyze gliadin polypeptides responsible for Celiac Sprue. „Biochim Biophys Acta.”, 2006-01. PMID: 16311022.
Paterson B.M., Lammers K.M., Arrieta M.C., Fasano A., Meddings J.B. The safety, tolerance, pharmacokinetic and pharmacodynamic effects of single doses of AT-1001 in coeliac disease subjects: a proof of concept study. „Aliment Pharmacol Ther.”, 2007-09. PMID: 17697209.
Liang L., Pinier M., Leroux J.C., Subirade M. Interaction of alpha-gliadin with poly(HEMA-co-SS): structural characterization and biological implication. „Biopolymers.”, 2009-02. PMID: 18975377.
Liang L., Pinier M., Leroux J.C., Subirade M. Interaction of alpha-gliadin with polyanions: design considerations for sequestrants used in supportive treatment of celiac disease. „Biopolymers.”, 2010-05. PMID: 19921745.
Gujral N., Löbenberg R., Suresh M., Sunwoo H. In-vitro and in-vivo binding activity of chicken egg yolk immunoglobulin Y (IgY) against gliadin in food matrix. „J Agric Food Chem.”, 2012-03. PMID: 22400905.
Ivarsson A., Hernell O., Stenlund H., Persson L.A. Breast-feeding protects against celiac disease. „Am J Clin Nutr.”, 2002-05. PMID: 11976167.
Annelie Carlsson1, Daniel Agardh, Stefan Borulf, Ewa Grodzinsky, Irene Axelsson and Sten-A. Ivarsson. Prevalence of celiac disease: Before and after a national change in feeding recommendations. „Scandinavian Journal of Gastroenterology”, 2006. PMID: 16638697.
Norris J.M., Barriga K., Hoffenberg E.J., Taki I., Miao D., Haas J.E., Emery L.M., Sokol R.J., Erlich H.A., Eisenbarth G.S., Rewers M. Risk of celiac disease autoimmunity and timing of gluten introduction in the diet of infants at increased risk of disease. „JAMA”, 2005-05. PMID: 15900004.
Losowsky MS. A history of coeliac disease. „Dig Dis.”, 2008. PMID: 18431060.
G.P. vanG.P.Berge-HenegouwenG.P. vanG.P., C.J.C.J.MulderC.J.C.J., Pioneer in the gluten free diet: Willem-Karel Dicke 1905-1962, over 50 years of gluten free diet, „Gut”, 34 (11), 1993, s. 1473–1475, ISSN0017-5749, PMID: 8244125, PMCID: PMC1374403 [dostęp 2018-11-10].
Anderson Cm, French Jm, Sammons Hg, Frazer Ac, Gerrard Jw, Smellie Jm. Coeliac disease; gastrointestinal studies and the effect of dietary wheat flour. „Lancet”, 1952-04-26. PMID: 14918439.
Marks J., Shuster S., Watson A.J. Small-bowel changes in dermatitis herpetiformis. „Lancet”, 1966-12. PMID: 4163419.
Alessio Fasano, Irene Berti, Tania Gerarduzzi, Tarcisio Not i inni. Prevalence of Celiac Disease in At-Risk and Not-At-Risk Groups in the United States. „Archives of Internal Medicine”. 163 (3), s. 286, 2003-02-10. American Medical Association (AMA). DOI: 10.1001/archinte.163.3.286. ISSN0003-9926. (ang.).
T Not, K Horvath, ID Hill, J Partanen i inni. Celiac disease risk in the USA: high prevalence of antiendomysium antibodies in healthy blood donors.. „Scandinavian Journal of Gastroenterology”. 33 (5), s. 494–8, 1998. ISSN0036-5521. PMID: 9648988. (ang.).
